Delivery Order SPE2DB22D3301-SPE2DB24FY5DC

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4,564,510,598 units of Topiramate Extended Release 200 mg Capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,090.34 and an ultimate completion date of May 7, 2024. The contract is not set aside for any specific business classification. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of topiramate extended-release 200 milligram capsules. The award is not set aside and has a ceiling value of $51,967.52. The contract is a firm-fixed-price type and has an ultimate completion date of July 29, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,750,490 capsules of topiramate extended-release 100 mg. The contract has a completion date of February 26, 2024 and a potential value of $1,462.56. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,531.57 firm fixed-price contract is for the supply of 100-count bottles of 100 mg topiramate extended-release capsules. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $22,406.92, is for the delivery of 4,564,109,231 units of topiramate ER 100 mg capsules. The contract has an ultimate completion date of March 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,624.21 contract is for the delivery of Topiramate ER 200 mg capsules, a prescription medication, with a period of performance ending on December 3, 2024. This Delivery Order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules. The order has a ceiling value of $35,216.26 and a performance period through August 20, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of topiramate extended-release 200 mg capsules. The contract has a period of performance through November 3, 2023 and a ceiling value of $12,842.53. It is a firm fixed-price delivery order contract and was not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of topiramate extended-release 100 mg capsules, a medication used to treat certain types of seizures and migraines. The contract has a ceiling value of $2,794.78 and a period of performance through May 8, 2023. It is a firm-fixed-price contract, meaning the price will not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $31,112.86 firm fixed price delivery order is for the provision of 4,564,328,195 units of Topiramate Extended Release 200 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY5DC
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of topiramate extended-release 200 mg capsules. The contract, valued at $1,448.64, has an ultimate completion date of April 22, 2024. The order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 7/19/24, 9:06 AM